Selected research
Industry Research
DNA Methylation Assay Industry Research Report 2026
Market perspective
The global DNA Methylation Assay market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the DNA Methylation Assay market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the DNA Methylation Assay market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the DNA Methylation Assay market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of DNA Methylation Assay include Illumina, Inc, Thermo Fisher Scientific, EpigenTek, GRAIL, New England Biolabs, Zymo Research, Diagenode, Agena Bioscience and EpigenDx. among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global DNA Methylation Assay market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to DNA Methylation Assay.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
DNA Methylation Assay Market by Company
Illumina, Inc
Thermo Fisher Scientific
EpigenTek
GRAIL
New England Biolabs
Zymo Research
Diagenode
Agena Bioscience
EpigenDx
DNA Methylation Assay Segment by Type
Loci-specific Methylation
Global Methylation
DNA Methylation Assay Segment by Application
Biopharmaceutical Companies
Research Institutions
Others
DNA Methylation Assay Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DNA Methylation Assay market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of DNA Methylation Assay and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DNA Methylation Assay.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of DNA Methylation Assay companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Loci-specific Methylation
- Global Methylation
Applications
- Biopharmaceutical Companies
- Research Institutions
- Others
Companies covered
- Illumina, Inc
- Thermo Fisher Scientific
- EpigenTek
- GRAIL
- New England Biolabs
- Zymo Research
- Diagenode
- Agena Bioscience
- EpigenDx
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 DNA Methylation Assay by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Loci-specific Methylation
- 2.2.3 Global Methylation
- 2.3 DNA Methylation Assay by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Biopharmaceutical Companies
- 2.3.3 Research Institutions
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 DNA Methylation Assay Breakdown Data by Type
- 3.1 Global DNA Methylation Assay Historic Market Size by Type (2021-2026)
- 3.2 Global DNA Methylation Assay Forecasted Market Size by Type (2027-2032)
4 DNA Methylation Assay Breakdown Data by Application
- 4.1 Global DNA Methylation Assay Historic Market Size by Application (2021-2026)
- 4.2 Global DNA Methylation Assay Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global DNA Methylation Assay Market Perspective (2021-2032)
- 5.2 Global DNA Methylation Assay Growth Trends by Region
- 5.2.1 Global DNA Methylation Assay Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 DNA Methylation Assay Historic Market Size by Region (2021-2026)
- 5.2.3 DNA Methylation Assay Forecasted Market Size by Region (2027-2032)
- 5.3 DNA Methylation Assay Market Dynamics
- 5.3.1 DNA Methylation Assay Industry Trends
- 5.3.2 DNA Methylation Assay Market Drivers
- 5.3.3 DNA Methylation Assay Market Challenges
- 5.3.4 DNA Methylation Assay Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top DNA Methylation Assay Players by Revenue
- 6.1.1 Global Top DNA Methylation Assay Players by Revenue (2021-2026)
- 6.1.2 Global DNA Methylation Assay Revenue Market Share by Players (2021-2026)
- 6.2 Global DNA Methylation Assay Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of DNA Methylation Assay Head Office and Area Served
- 6.4 Global DNA Methylation Assay Players, Product Type & Application
- 6.5 Global DNA Methylation Assay Manufacturers Established Date
- 6.6 Global DNA Methylation Assay Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America DNA Methylation Assay Market Size (2021-2032)
- 7.2 North America DNA Methylation Assay Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America DNA Methylation Assay Market Size by Country (2021-2026)
- 7.4 North America DNA Methylation Assay Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe DNA Methylation Assay Market Size (2021-2032)
- 8.2 Europe DNA Methylation Assay Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe DNA Methylation Assay Market Size by Country (2021-2026)
- 8.4 Europe DNA Methylation Assay Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific DNA Methylation Assay Market Size (2021-2032)
- 9.2 Asia-Pacific DNA Methylation Assay Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific DNA Methylation Assay Market Size by Country (2021-2026)
- 9.4 Asia-Pacific DNA Methylation Assay Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America DNA Methylation Assay Market Size (2021-2032)
- 10.2 South America DNA Methylation Assay Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America DNA Methylation Assay Market Size by Country (2021-2026)
- 10.4 South America DNA Methylation Assay Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa DNA Methylation Assay Market Size (2021-2032)
- 11.2 Middle East & Africa DNA Methylation Assay Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa DNA Methylation Assay Market Size by Country (2021-2026)
- 11.4 Middle East & Africa DNA Methylation Assay Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Illumina, Inc
- 12.1.1 Illumina, Inc Company Information
- 12.1.2 Illumina, Inc Business Overview
- 12.1.3 Illumina, Inc Revenue in DNA Methylation Assay Business (2021-2026)
- 12.1.4 Illumina, Inc DNA Methylation Assay Product Portfolio
- 12.1.5 Illumina, Inc Recent Developments
- 12.2 Thermo Fisher Scientific
- 12.2.1 Thermo Fisher Scientific Company Information
- 12.2.2 Thermo Fisher Scientific Business Overview
- 12.2.3 Thermo Fisher Scientific Revenue in DNA Methylation Assay Business (2021-2026)
- 12.2.4 Thermo Fisher Scientific DNA Methylation Assay Product Portfolio
- 12.2.5 Thermo Fisher Scientific Recent Developments
- 12.3 EpigenTek
- 12.3.1 EpigenTek Company Information
- 12.3.2 EpigenTek Business Overview
- 12.3.3 EpigenTek Revenue in DNA Methylation Assay Business (2021-2026)
- 12.3.4 EpigenTek DNA Methylation Assay Product Portfolio
- 12.3.5 EpigenTek Recent Developments
- 12.4 GRAIL
- 12.4.1 GRAIL Company Information
- 12.4.2 GRAIL Business Overview
- 12.4.3 GRAIL Revenue in DNA Methylation Assay Business (2021-2026)
- 12.4.4 GRAIL DNA Methylation Assay Product Portfolio
- 12.4.5 GRAIL Recent Developments
- 12.5 New England Biolabs
- 12.5.1 New England Biolabs Company Information
- 12.5.2 New England Biolabs Business Overview
- 12.5.3 New England Biolabs Revenue in DNA Methylation Assay Business (2021-2026)
- 12.5.4 New England Biolabs DNA Methylation Assay Product Portfolio
- 12.5.5 New England Biolabs Recent Developments
- 12.6 Zymo Research
- 12.6.1 Zymo Research Company Information
- 12.6.2 Zymo Research Business Overview
- 12.6.3 Zymo Research Revenue in DNA Methylation Assay Business (2021-2026)
- 12.6.4 Zymo Research DNA Methylation Assay Product Portfolio
- 12.6.5 Zymo Research Recent Developments
- 12.7 Diagenode
- 12.7.1 Diagenode Company Information
- 12.7.2 Diagenode Business Overview
- 12.7.3 Diagenode Revenue in DNA Methylation Assay Business (2021-2026)
- 12.7.4 Diagenode DNA Methylation Assay Product Portfolio
- 12.7.5 Diagenode Recent Developments
- 12.8 Agena Bioscience
- 12.8.1 Agena Bioscience Company Information
- 12.8.2 Agena Bioscience Business Overview
- 12.8.3 Agena Bioscience Revenue in DNA Methylation Assay Business (2021-2026)
- 12.8.4 Agena Bioscience DNA Methylation Assay Product Portfolio
- 12.8.5 Agena Bioscience Recent Developments
- 12.9 EpigenDx
- 12.9.1 EpigenDx Company Information
- 12.9.2 EpigenDx Business Overview
- 12.9.3 EpigenDx Revenue in DNA Methylation Assay Business (2021-2026)
- 12.9.4 EpigenDx DNA Methylation Assay Product Portfolio
- 12.9.5 EpigenDx Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst